|
|
|
OCLS - Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences, Inc. (OCLS) is a specialty pharmaceutical company that develops, manufactures, and markets products for the dermatology, wound care, and animal healthcare markets. The company's proprietary technology platform is based on Microcyn® Technology, which is a non-toxic, stable, and broad-spectrum antimicrobial that is used in its products.
Oculus Innovative Sciences has developed a range of products based on its Microcyn Technology, including wound care products, such as MicrocynAH® for animal healthcare, and Dermacyn® for the dermatology market. The company's products are designed to provide effective and safe treatment options for a wide range of skin conditions, including dermatitis, eczema, acne, and other inflammatory skin conditions.
The company's products are sold in the United States, Mexico, and several other international markets. Oculus Innovative Sciences has collaborations with a number of pharmaceutical and biotechnology companies, including ECR Pharmaceuticals, Incepta Pharmaceuticals, and Medline Industries, among others.
|
|
|
|
|
